Entrada Therapeutics, Inc.

NASDAQ:TRDA

12.25 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -14.03255.03123.496-9.54435.461-25.928-6.674-24.629-25.137-23.179-21.671-18.447-14.43-9.901-8.38-8.673-6.99-5.43-5.43
Depreciation & Amortization 0.9370.910.9340.7360.8340.730.5410.5250.5140.4660.390.3640.3020.2520.1990.0980.090.0690.069
Deferred Income Tax 000-3.76000000000000000
Stock Based Compensation 4.864.6223.7333.8413.3963.1192.7552.8822.7072.5121.7941.4580.5780.3260.1640.0980.0750.0760.076
Change In Working Capital -12.818-18.469-51.6452.953-62.331-11.321207.014-5.979-5.5362.05-1.646-3.837-0.6781.413-0.3191.841.18-1.525-1.525
Accounts Receivables 5.07169.84-71.636-0.853-1.2812.553-6.297000000000000
Change In Inventory 0004.0241.281-2.5536.297000000000000
Change In Accounts Payables -0.314-0.886-0.6552.406-1.365-4.380.5344.593-2.9071.542.061-1.0260.080.499-0.268-0.0780.39800
Other Working Capital -17.575-87.42320.646-2.624-60.966-6.941206.48-10.572-2.6290.51-3.707-2.811-0.7580.914-0.0511.9180.782-1.525-1.525
Other Non Cash Items -3.213-2.261-2.0371.761-1.852-1.691-0.237-0.103-0.030.1420.142-0.0790.153000.01300.1590.159
Operating Cash Flow -24.26639.833-25.519-4.013-24.492-35.091203.399-27.304-27.482-18.009-20.991-20.541-14.075-7.91-8.336-6.624-5.645-6.651-6.651
Investing Activities:
Investments In Property Plant And Equipment -0.639-1.046-0.838-0.976-1.448-1.522-1.668-0.708-0.81-0.775-0.594-1.322-0.806-1.544-0.908-1.451-0.237-0.319-0.319
Acquisitions Net 000-152.82.289111.73538.77609.3240000000000
Purchases Of Investments -165.593-110.692-96.935-88.521-76.789-140.121-101.7760-39.3240-182.65300000000
Sales Maturities Of Investments 83.30587.355123.92108.5474.528.3866319.530251.71400000000
Other Investing Activites 0-23.33726.98520.019-2.289-111.735-38.77619.5-9.3242500000000.0040.004
Investing Cash Flow -82.927-24.38326.14719.043-3.737-113.257-40.44418.792-10.13424.225-181.533-1.322-0.806-1.544-0.908-1.451-0.237-0.315-0.315
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued -0.011101.3670.2060.690.3680.44319.4070.3580.060.011000000000
Common Stock Repurchased 0000.443000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities -0.011101.3670.2060.690.3680.4430.1290.3580.060.0110.05190.7550.106-0.202116.3850.14924.86412.53812.538
Financing Cash Flow -0.011101.3670.2060.690.3680.44319.5360.3580.060.0110.05190.7550.1060.215116.3850.14924.86412.53812.538
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000
Net Change In Cash -107.204116.8170.83415.72-27.861-147.905182.491-8.154-37.5566.227-202.474168.892-14.775-9.239107.141-7.92618.9825.5735.573
Cash At End Of Period 81.999189.20372.38667.60255.83283.693231.59849.10757.26194.81788.59291.064122.172136.947146.18639.04546.97127.9895.573